William Lis - Jun 24, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Jun 24, 2022
Transactions value $
-$101,434
Form type
4
Date filed
6/28/2022, 04:01 PM
Previous filing
Mar 23, 2022
Next filing
Oct 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Sale -$50K -24.7K -27.5% $2.02 65.2K Jun 24, 2022 Direct F1, F2
transaction JSPR Voting Common Stock Sale -$51.4K -24.7K -37.93% $2.08 40.5K Jun 27, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $2.30, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Remarks:

Executive Chairman of the Board